Daratumumab and atezolizumab to be evaluated in two studies
22 March 2016 | By Victoria White
The studies will assess the combination of daratumumab and atezolizumab in multiple myeloma and in solid tumour cancer...
List view / Grid view
News
Pharmapack Europe integral to anti-counterfeiting efforts
22 March 2016 | By Victoria White
Pharmapack Europe, organised by UBM EMEA, held its most successful event yet at the Paris expo Porte De Versailles on the 10th and 11th of February 2016...
Pfizer announces results from studies of tofacitinib in ulcerative colitis
21 March 2016 | By Victoria White
Results from OCTAVE Induction 1 and 2, evaluating the efficacy and safety of oral tofacitinib in inducing remission in ulcerative colitis, were presented at ECCO...
MSD presents data from Simponi GO-COLITIS trial
21 March 2016 | By Victoria White
GO-COLITIS evaluated the efficacy of Simponi (golimumab) in inducing and maintaining clinical response in patients with moderate to severe ulcerative colitis...
NICE recommends abiraterone for some prostate cancer patients
21 March 2016 | By Victoria White
Professor Paul Workman of The Institute of Cancer Research, which discovered abiraterone, said the recommendation was “a big victory for men"...
Enstilar receives scientific approval in the EU for psoriasis
21 March 2016 | By Victoria White
Enstilar is a topical spray foam treatment for psoriasis that is designed to provide patients with a convenient treatment option that can be easily applied...
NICE recommends Novartis’ heart failure drug, Entresto
21 March 2016 | By Victoria White
The UK’s National Institute for Health and Care Excellence (NICE) has recommended Novartis’ heart failure drug, Entresto (sacubitrial/valsartan).
Positive top-line results from Phase III study of romosozumab in osteoporosis
21 March 2016 | By Victoria White
The study demonstrated a statistically significant increase in bone mineral density at the lumbar spine in men with osteoporosis treated with romosozumab...
Yusen Logistics builds Logistics Center to expand service in Mexico auto market
Yusen Logistics, a leading third-party logistics provider, announced the start of construction of a logistics center near Celaya, Mexico, to meet the growing demands of its domestic and international automotive customers.
Gastric cancer treatment development shifting to mAbs
17 March 2016 | By Victoria White
The dominance of small molecules in the gastric cancer treatment space could be about to give way to monoclonal antibodies, according to GBI Research...
Allergan files ANDA to the FDA for generic Abraxane
17 March 2016 | By Victoria White
Allergan believes it is a first applicant to file an ANDA for generic Abraxane and, should it be approved, may get 180 days of generic market exclusivity...
Sir Andrew Witty to retire as CEO of GSK
17 March 2016 | By Victoria White
GSK has announced that Sir Andrew Witty, CEO, has indicated to the Board his intention to retire from the company in early 2017...
GSK’s Advair Diskus achieves primary endpoint in LABA safety study
17 March 2016 | By Victoria White
The VESTRI study compared Advair Diskus to fluticasone propionate monotherapy in children aged 4 – 11 years who have asthma...
First patient dosed in Halozyme’s PEGPH20 pancreatic cancer trial
17 March 2016 | By Victoria White
The trial will study PEGPH20 in combination with nab-paclitaxel and gemcitabine in patients with tumours that accumulate high levels of hyaluronan...
Amgen wins drug patent case against Sanofi and Regeneron
17 March 2016 | By Victoria White
A jury has delivered a verdict in Amgen's favour in a trial on the validity of two Amgen patents that describe and claim monoclonal antibodies to PCSK9...
